Dr. Donald E. Palm III has spent more than three decades in higher education, working in the research lab, the classroom, the provost’s office and the executive cabinet. The Pittsburgh native is now executive vice president for Health Sciences Enterprise and Research Innovation at Florida A&M University (FAMU), and he has been named a H.E.L.F. Fellow in the inaugural Alpha Cohort of "Who’s Got Next", The Ascension Series.
“I am deeply humbled and honored to be selected as a member of the inaugural Alpha Cohort of Fellows,” Palm told The H.E.L.F Review. “I view this distinction not simply as recognition of a leadership journey, but as a profound responsibility to continue growing, serving, and preparing to lead with vision, integrity, and purpose.”
Palm trained as a scientist. He earned a bachelor’s degree in chemistry from Lincoln University of Pennsylvania, the nation’s first degree-granting HBCU, and a Ph.D. in pharmacology from Penn State’s Hershey Medical Center. He completed postdoctoral training in the Department of Neurosurgery at Brown University and Rhode Island Hospital, and his research has centered on neurodegeneration. Over his career, he has secured millions of dollars for STEM education and research programs.
He joined FAMU as a faculty member in the College of Pharmacy and Pharmaceutical Sciences’ Institute of Public Health, earned tenure, and later became associate provost for undergraduate studies. He was an American Council on Education (ACE) Fellow in 2011–2012 and completed the Management Development Program at Harvard’s Graduate School of Education.
In 2016, Palm left FAMU for Virginia State University (VSU), where he became provost and vice president for academic affairs. He was later named executive vice president and provost, with added responsibility for student affairs and research.
His tenure in Petersburg left a mark on nearly every part of the university. He guided VSU through its 2018 SACSCOC reaffirmation of accreditation without a single recommendation, and in 2020 he oversaw development of its five-year strategic plan, “Preeminence with Purpose.” He secured a record $250 million in capital funding and $48 million in operating support from the Commonwealth of Virginia, and sponsored research spending climbed to an all-time high of $28.9 million.
VSU added eight degree programs, six fully online programs and 10 institutes and centers during those years. It enrolled its largest incoming class in more than 30 years, and its four-year graduation rate reached the highest point in school history.
Palm also commissioned a salary-equity study and a campus climate survey, and the findings produced a more competitive pay plan for faculty and staff. He invested in employees through mentoring initiatives, leadership programs, travel awards, and performance recognition.
Palm returned to FAMU on Aug. 14, 2023, as executive vice president and chief operating officer. In April 2025, the News Service of Florida included him on its 50 Over 50 list. That spring, he was also one of four finalists for the FAMU presidency.
In August 2025, President Marva Johnson appointed him to the newly created post he holds today. He oversees FAMU’s colleges of allied health, nursing, pharmacy, and public health, and he leads the research agenda as the university pursues Carnegie R1 status. Johnson said Palm “is uniquely positioned to lead transformative research growth while honoring the FAMU land-grant mission.” This year, he is also co-chairing FAMU’s new strategic planning initiative.
Palm is a member of Sigma Pi Phi (the Boulé) and Alpha Phi Alpha Fraternity, Inc. He is also a 33rd-degree Prince Hall Mason in the United Supreme Council and a Prince Hall Shriner. He and his wife, Nekisha, have three children, Brandon, Qu’Riya and Donovan.
Palm said the fellowship strengthens his resolve to advance higher education, support HBCUs, and open doors for generations to come.
“Leadership is not about the position we hold, but the lives we impact and the legacy we leave behind,” he said.




